Roger Eugene Bumgarner

Dr. Roger Eugene Bumgarner


Research Focus & Metrics

Academic Career Length

43Years (1984-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 February 2008 in Nature Biotechnology
Verified
Journal Article
Closed access
PDF file
GGGary K Geiss
Gary K Geiss
RBRoger Eugene Bumgarner
Roger Eugene Bumgarner
BBBrian Birditt
Brian Birditt
TDTimothy Dahl
Timothy Dahl
NDNaeem Dowidar
Naeem Dowidar
KDKrassen Dimitrov
Krassen Dimitrov

29 August 2010 in Nature Genetics
Verified
Journal Article
Closed access
Riccardo VelascoRiccardo Velasco
Riccardo Velasco
AZAndrey Zharkikh
Andrey Zharkikh
JAJason Affourtit
Jason Affourtit
ADAmit Dhingra
Amit Dhingra
ACAlessandro Cestaro
Alessandro Cestaro
RVRoberto Viola
Roberto Viola

4 May 2001 in Science
Verified
Journal Article
Closed access
PDF file
TITrey Ideker
Trey Ideker
VTVesteinn Thorsson
Vesteinn Thorsson
JRJeffrey A. Ranish
Jeffrey A. Ranish
RCRowan Christmas
Rowan Christmas
JBJeremy Buhler
Jeremy Buhler
LHLeroy Hood
Leroy Hood
We demonstrate an integrated approach to build, test, and refine a model of a cellular pathway, in which perturbations to critical pathway components are analyzed using DNA microarrays, quantitative proteomics, and databases of known physical interactions. Using this approach, we identify 997 messenger RNAs responding to 20 systematic perturbations of the yeast galactose-utilization pathway, provide evidence that approximately 15 of 289 detected proteins are regulated posttranscriptionally, and identify explicit physical interactions governing the cellular response to each perturbation. We refine the model through further iterations of perturbation and global measurements, suggesting hypotheses about the regulation of galactose utilization and physical interactions between this and a variety of other metabolic pathways.

13 April 2007 in Science
Verified
Journal Article
Closed access
PDF file
RGRichard A. Gibbs
Richard A. Gibbs
JRJeffrey Rogers
Jeffrey Rogers
MKMichael G. Katze
Michael G. Katze
RBRoger Eugene Bumgarner
Roger Eugene Bumgarner
GWGeorge Weinstock
George Weinstock
AZAnn S. Zwieg
Ann S. Zwieg
The rhesus macaque ( Macaca mulatta ) is an abundant primate species that diverged from the ancestors of Homo sapiens about 25 million years ago. Because they are genetically and physiologically similar to humans, rhesus monkeys are the most widely used nonhuman primate in basic and applied biomedical research. We determined the genome sequence of an Indian-origin Macaca mulatta female and compared the data with chimpanzees and humans to reveal the structure of ancestral primate genomes and to identify evidence for positive selection and lineage-specific expansions and contractions of gene families. A comparison of sequences from individual animals was used to investigate their underlying genetic diversity. The complete description of the macaque genome blueprint enhances the utility of this animal model for biomedical research and improves our understanding of the basic biology of the species.

1 October 2001 in Nature
Verified
Journal Article
Closed access
MWMarvin Whiteley
Marvin Whiteley
MBM. Gita Bangera
M. Gita Bangera
RBRoger Eugene Bumgarner
Roger Eugene Bumgarner
MPMatthew R. Parsek
Matthew R. Parsek
GTGail M. Teitzel
Gail M. Teitzel
EGE. P. Greenberg
E. P. Greenberg

18 June 2012 in PLOS ONE
Verified
Journal Article
Open access
PDF file
SSSujatha Srinivasan
Sujatha Srinivasan
NHNoah G. Hoffman
Noah G. Hoffman
MMMartin T. Morgan
Martin T. Morgan
FMFrederick A. Matsen
Frederick A. Matsen
TFTina L. Fiedler
Tina L. Fiedler
DFDavid N. Fredricks
David N. Fredricks
Bacterial vaginosis (BV) is a common condition that is associated with numerous adverse health outcomes and is characterized by poorly understood changes in the vaginal microbiota. We sought to describe the composition and diversity of the vaginal bacterial biota in women with BV using deep sequencing of the 16S rRNA gene coupled with species-level taxonomic identification. We investigated the associations between the presence of individual bacterial species and clinical diagnostic characteristics of BV. Broad-range 16S rRNA gene PCR and pyrosequencing were performed on vaginal swabs from 220 women with and without BV. BV was assessed by Amsel’s clinical criteria and confirmed by Gram stain. Taxonomic classification was performed using phylogenetic placement tools that assigned 99% of query sequence reads to the species level. Women with BV had heterogeneous vaginal bacterial communities that were usually not dominated by a single taxon. In the absence of BV, vaginal bacterial communities were dominated by either Lactobacillus crispatus or Lactobacillus iners. Leptotrichia amnionii and Eggerthella sp. were the only two BV-associated bacteria (BVABs) significantly associated with each of the four Amsel’s criteria. Co-occurrence analysis revealed the presence of several sub-groups of BVABs suggesting metabolic co-dependencies. Greater abundance of several BVABs was observed in Black women without BV. The human vaginal bacterial biota is heterogeneous and marked by greater species richness and diversity in women with BV; no species is universally present. Different bacterial species have different associations with the four clinical criteria, which may account for discrepancies often observed between Amsel and Nugent (Gram stain) diagnostic criteria. Several BVABs exhibited race-dependent prevalence when analyzed in separate groups by BV status which may contribute to increased incidence of BV in Black women. Tools developed in this project can be used to study microbial ecology in diverse settings at high resolution.